Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze KZIA stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate KZIA investment potential.

What is KZIA stock price today?

Get real-time KZIA stock price, historical data, and price charts on Financhill. Track KZIA performance with our advanced analysis tools.

Is KZIA a good investment?

Evaluate KZIA investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy KZIA stock?

To buy KZIA stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of KZIA?

View detailed market capitalization data and company valuation metrics for KZIA on our comprehensive analysis page.

What is the P/E ratio of KZIA?

Use our fundamental analysis tools to view KZIA P/E ratio and compare valuation metrics with industry peers.

What are KZIA earnings?

View KZIA earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Kazia Therapeutics Ltd. 10K Form

Buy

KZIA
Kazia Therapeutics Ltd.

Last Price:

$13.30

Seasonality Move:

10.38%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive KZIA News And Ratings

See the #1 stock for the next 7 days that we like better than KZIA

KZIA Financial Statistics

Sales & Book Value

Annual Sales:	$27.2K
Cash Flow:	$0
Price / Cash Flow:	0
Annual Sales:	$-2.01
Price / Book:	2.19

Profitability

EPS (TTM):	-6.66830
Net Income (TTM):	$-17.6M
Gross Margin:	$-577.7K
Return on Equity:	-1083.16%
Return on Assets:	-106.28%

Kazia Therapeutics Ltd. Earnings Forecast

Key Kazia Therapeutics Ltd. Financial Ratios

The Gross Profit Margin over the past 30 years for KZIA is -2,123.90%.
The Selling, General & Administrative Expenses for KZIA have been equal to 20,762.13% of Gross Profit Margin.
The Research & Development expenses have been 15,219.49% of Revenue.
The Net Earning history of KZIA is -49,291.54% of Total Revenues.
Per Share Earnings over the last 30 years have been positive in 19 years.

Kazia Therapeutics Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	KZIA
CUSIP:	48669G
Website:	kaziatherapeutics.com

Debt

Debt-to-Equity Ratio:	-0.06
Current Ratio:	0.24
Quick Ratio:	0.07

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

KZIA Technical Analysis vs Fundamental Analysis

Buy

Kazia Therapeutics Ltd. (KZIA) is a Buy

Is Kazia Therapeutics Ltd. a Buy or a Sell?

Kazia Therapeutics Ltd. stock is rated a Buy

The current Kazia Therapeutics Ltd. [KZIA] share price is $13.25. The Score for KZIA is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.